Concepedia

Alison Reid

AR

21

Publications

3.6K

Citations

17

H-Index

1974

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

University of Manchester

Churchill Hospital

Alison Reid is an author at Institute of Cancer Research specializing in medicine, oncology, and pharmacotherapy.

Top concepts

MedicineOncologyUrologyPharmacologyPharmacotherapyPathologySurgical OncologyRadiation OncologyArtsSurgery

Publications per year

1974–2022

21

Publications

21

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Gerhardt Attard, Alison Reid, Timothy A. Yap et al. · Journal of Clinical Oncology · 2008 · 893 citations · Full text

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

Gerhardt Attard, Alison Reid, Roger A’Hern et al. · Journal of Clinical Oncology · 2009 · 600 citations · Full text

Characterization of <i>ERG</i> , <i>AR</i> and <i>PTEN</i> Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer

Gerhardt Attard, Joost F. Swennenhuis, David Olmos et al. · Cancer Research · 2009 · 531 citations · Full text

Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

Alison Reid, Gerhardt Attard, Daniel C. Danila et al. · Journal of Clinical Oncology · 2010 · 394 citations · Full text

Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer

Gerhardt Attard, Alison Reid, Richard J. Auchus et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 267 citations

Rows per page

1–5 of 21